Medicago medicago.com


Public list: BIO 2016 (619) Pharma Startups (4732)

Medicago is committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has potential to offer advantages of speed and cost over competitive technologies. It could deliver a vaccine for testing in about a month after ...Show all

Medicago is committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient...Show all

Company (Acquired)

Phone: 418-658-9393

Fax:

1020, route de l'Église
bureau 600
Quebec City, G1V 3V9
Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Medicago $0.5M Sep 18, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Medicago Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Medtech PartnersUnattributed VC
T2C2 CapitalUnattributed VC
CQVBCanadaUnattributed VC
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for recovering plant-derived proteins Mar 23, 2012 Nov 14, 2017 Patent
Synthesis of sialic acid in plants Nov 04, 2015 May 23, 2017 Patent
Influenza virus immunizing epitope Jul 15, 2009 Jan 17, 2017 Patent
Influenza virus-like particles (vlps) comprising hemagglutinin Jul 02, 2009 Nov 15, 2016 Patent
Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin Jan 23, 2013 Oct 04, 2016 Patent
See all 22 patents